Nu-Med Plus (NUMD) Cash from Financing Activities (2012 - 2025)
Nu-Med Plus' (NUMD) quarterly Cash from Financing Activities came in at $33767.0 in Q4 2025, up 170.14% quarter-over-quarter from $12500.0 in Q3 2025.
Powered by 
Analysis
Nu-Med Plus (NUMD) Cash from Financing Activities (2012 - 2025) Analysis & Trends
Nu-Med Plus has disclosed Cash from Financing Activities across 11 years of filings, most recently posting $33767.0 for Q4 2025.
- In Q4 2025, Cash from Financing Activities changed N/A year-over-year to $33767.0; the TTM figure through Dec 2025 stood at $46267.0 (changed N/A YoY), while the FY2025 annual figure was $46267.0, changed N/A from the prior year.
- Cash from Financing Activities came in at $33767.0 for Q4 2025 at Nu-Med Plus, up from $12500.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $33767.0 in Q4 2025 to a low of $12500.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | -343.00 Mn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | -95.00 Mn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | -410.00 Mn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | -300,000.00 |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -510.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | -607.30 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 33,767.00 |
| Sep 30, 2025 | 12,500.00 |
| Mar 31, 2021 | 30,000.00 |
| Dec 31, 2020 | 228,260.00 |
| Sep 30, 2020 | 126,412.00 |
| Jun 30, 2020 | 135,115.00 |
| Mar 31, 2020 | 106,439.00 |
| Dec 31, 2019 | 89,906.00 |
| Sep 30, 2019 | 101,614.00 |
| Jun 30, 2019 | 112,929.00 |
| Mar 31, 2019 | 102,458.00 |
| Dec 31, 2018 | 142,580.00 |
| Sep 30, 2018 | 22,795.00 |
| Jun 30, 2018 | 117,556.00 |
| Mar 31, 2018 | 6,132.00 |
| Dec 31, 2017 | 80,910.00 |
| Sep 30, 2017 | 273,606.00 |
| Jun 30, 2017 | 35,587.00 |
| Mar 31, 2017 | 379,000.00 |
| Dec 31, 2016 | 52,311.00 |